AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 May ETF (ARCA: MAYT)

Latest news for AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 May ETF (ARCA:MAYT)

The Fund invests at least 80% of its net assets in instruments with economic characteristics similar to U.S. large cap equity securities. Specifically, the Fund intends to invest substantially all of its assets in FLexible EXchange Options (FLEX Options) that reference the Underlying ETF. FLEX Options are customized equity or index options contracts that trade on an exchange, but provide investors with the ability to customize key contract terms like exercise prices, styles and expiration dates. An options contract is an agreement between a buyer and seller that gives the purchaser of the option the right, but not the obligation, to buy (in the case of a call option), or to sell (in the case of a put option), a particular asset at a specified future date at an agreed upon price (commonly known as the strike price). The Fund is classified as non-diversified under the Investment Company Act of 1940, as amended (the 1940 Act).

AllianzIM US Large Cap Buffer10 May ETF

AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 May ETF

Stifel analyst Nathan Jones maintains ESAB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESAB#NYSE">ESAB</a>) with a Buy and lowers the price target from $130 to $120.

News

Price Target

Analyst Ratings

ESAB

Stifel Maintains Buy on ESAB, Lowers Price Target to $120

Guidance

United Airlines Exec Says Demand For Flights To China Is Down Dramatically Versus 2019

Stifel analyst Nathan Jones maintains Dnow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNOW#NYSE">DNOW</a>) with a Buy and raises the price target from $16 to $17.

DNOW

Stifel Maintains Buy on Dnow, Raises Price Target to $17

RDZN

Roadzen CEO And Chairman To Exchange $3.5M Of Short-Term Debt For Company Equity

Macro Economic Events

WIIM

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are lower amid recent weakness in tech stocks.

Trading Ideas

ZVSA

ZyVersa Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 7.59%

<ul>
<li>Publication showed that IC 100 suppressed retinal microglia activation by interfering with ASC speck formation, attenuating retinal inflammation, abnormal retinal vascularization, and retinal thinning, and it led to restored retinal function. &nbsp;</li>
<li>Retinopathy of Prematurity (ROP), affecting very low birth weight premature infants is a leading cause of childhood blindness worldwide.
<ul>
<li>ZyVersa is developing Inflammasome ASC Inhibitor IC 100 to inhibit multiple types of inflammasomes and their associated ASC specks that trigger damaging inflammation and its perpetuation and spread to surrounding tissues.</li>
</ul>
</li>
</ul>

Biotech

General

ZyVersa Therapeutics Publish Paper In Angiogensis Peer-Review Journal That Demonstrated Inflammasome ASC Inhibitor IC 100 Restored Retinal Structure And Function In Retinopathy Of Prematurity Animal Model

GPCR

Shares of weight loss stocks are trading lower, possibly on continued weakness following recent weight loss data from Roche, which could cause competition concerns for companies in the space.

United Airlines Exec Says At This Point, Expect Domestic PRASM To Flip To Positive In September

WABC

During The Twelve Months Ending June 30, 2025, Westamerica Bancorporation Expects To Receive $309,000 In Principal Payments From Debt Securities.

Stephens &amp; Co. analyst Terry McEvoy reiterates Wintrust Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>) with a Overweight and maintains $115 price target.

Reiteration

WTFC

Stephens & Co. Reiterates Overweight on Wintrust Finl, Maintains $115 Price Target

Westamerica Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WABC#NASDAQ">WABC</a>) reported quarterly earnings of $1.33 per share which beat the analyst consensus estimate of $1.30 by 2.31 percent. The company reported quarterly sales of $74.600 million which beat the analyst consensus estimate of $74.040 million by 0.76 percent. This is a 7.88 percent decrease over sales of $80.981 million the same period last year.

Earnings

Earnings Beats

Westamerica Bancorp Q2 2024 GAAP EPS $1.33 Beats $1.30 Estimate, Sales $74.600M Beat $74.040M Estimate

PDF Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDFS#NYSE">PDFS</a>) short percent of float has risen 7.14% since its last report. The company recently reported that it has 527 thousand shares sold short, which is 1.8% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.47 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>PDF Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721315721_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PDF Solutions has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PDF Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, PDF Solutions's peer group average for short interest as a percentage of float is 7.40%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

PDFS

Looking Into PDF Solutions's Recent Short Interest

NextEra Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) short percent of float has risen 9.41% since its last report. The company recently reported that it has 38.16 million shares sold short, which is 1.86% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NextEra Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721315716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NextEra Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NextEra Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NextEra Energy's peer group average for short interest as a percentage of float is 2.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into NextEra Energy's Recent Short Interest

Hartford Finl Servs Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) short percent of float has fallen 8.06% since its last report. The company recently reported that it has 4.38 million shares sold short, which is 1.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Hartford Finl Servs Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721315711_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Hartford Finl Servs Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Hartford Finl Servs Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Hartford Finl Servs Gr's peer group average for short interest as a percentage of float is 2.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Hartford Finl Servs Gr's Recent Short Interest

Barclays analyst Blayne Curtis maintains NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) with a Overweight and raises the price target from $280 to $330.

NXPI

Barclays Maintains Overweight on NXP Semiconductors, Raises Price Target to $330

Blackstone Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) shares are trading higher after it reported second-quarter fiscal year 2024 adjusted revenues of $2.796 billion, beating the consensus of $2.619 <a href="https://s23.q4cdn.com/714267708/files/doc_financials/2024/q2/Blackstone2Q24EarningsPressRelease.pdf" target="_blank" rel="noreferrer noopener">billion</a>. 
Distributable earnings (DE) rose&nbsp;3%&nbsp;Y/Y to&nbsp;$1.25 billion. Fee-related earnings fell&nbsp;3%&nbsp;Y/Y to&nbsp;$1.11 billion.
Fee-related earnings fell&nbsp;18%&nbsp;Y/Y in the Real Estate&nbsp;while rising 29%&nbsp;in the Credit &amp; Insurance business and 1%&nbsp;Y/Y in the Private Equity segments.
Net accrued performance revenue declined to&nbsp;$6.21 billion&nbsp;in the quarter from&nbsp;$6.47 billion&nbsp;in the prior year quarter.&nbsp;
Distributable earnings per share of&nbsp;$0.96 (+3% Y/Y),<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener"> missing the consensus of&nbsp;$0.98</a>.
Asset under management rose&nbsp;7%&nbsp;Y/Y to&nbsp;$1.076 trillion, with inflows of&nbsp;$39.4 billion&nbsp;in the quarter.
Dividend: Blackstone declared a quarterly dividend per share of&nbsp;$0.82, payable on August 5, 2024, to shareholders of record as of July 29, 2024.
Buyback: The company repurchased 2.0 million shares in the&nbsp;second quarter. Blackstone increased share repurchase authorization to $2.0 billion.
"We reported another quarter of strong results, underpinned by nearly $40 billion of inflows and $34 billion of deployment — reflecting the highest level of investment activity in two years,&#8221; Blackstone CEO Stephen A. Schwarzman said.
This week, Blackstone disclosed that private equity funds affiliated with the firm entered into a definitive agreement to acquire Trystar, a premier provider of electrical equipment<a href="https://www.benzinga.com/markets/equities/24/07/39799606/whats-going-on-with-blackstone-shares-today" target="_blank" rel="noreferrer noopener"> used for backup power solutions</a>.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BX stock has gained over 30% in the past year. Investors can gain exposure to the stock via&nbsp;EA Series Trust WHITEWOLF Publicly Listed Private Equity ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/LBO#BATS">LBO</a>) and Invesco Global Listed Private Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSP#NYSE">PSP</a>).
Price Action: BX shares are up&nbsp;3.76%&nbsp;to&nbsp;$139.93 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39593979/blackstone-nears-2-2b-deal-for-sale-of-japanese-supplement-maker-alinamin-report" target="_blank" rel="noreferrer noopener">Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report</a></li>
</ul>
Image: Shutterstock

Equities

Large Cap

Dividends

Blackstone's Strong Q2 Drives Stock Higher: Assets Under Management Up 7%

Crypto trader CrypNuevo shared a detailed Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) forecast, predicting a <a href="https://www.benzinga.com/money/bitcoin-price-prediction">bullish mid-term target</a>.
What Happened: CrypNuevo addressed three key questions: the target of a potential retrace, the new CME gap and upside targets.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> update: I&#39;m feeling confident with my plan and I believe that the next natural mid-term target is the range highs. In this analysis, I&#39;ll try to answer these 3 question&#x1f9f5; Q1: What&#39;s the target of a potential retrace? Q2: What about the new CME gap? Q3: Upside targets? <a href="https://t.co/6OjSAw8wK1">pic.twitter.com/6OjSAw8wK1</a>
&mdash; CrypNuevo &#x1f528; (@CrypNuevo) <a href="https://twitter.com/CrypNuevo/status/1813662658866098252?ref_src=twsrc%5Etfw">July 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
For a potential retrace, CrypNuevo suggested that many are predicting a retest of the $60,000 range lows, but he believes it&#8217;s less likely to occur. He identified chart targets between $61,500 and $62,500, and liquidity targets at $62,000 and $61,700. By combining these, he proposed an ideal area between $62,500 and $61,700.
Regarding the new CME gap, he stated, "Big CME gaps don&#8217;t necessarily get filled immediately." He cited previous examples where a delay of at least 50 days was common, implying that the current CME gap doesn&#8217;t need to be filled right away.
Addressing his last question, the trader identified the untapped highs between $71,500 and $73,700 as the next natural move. He also mentioned the liquidations at $68,000 as a good first-take profit area for a swing long.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39821600/trump-bitcoin-ethereum-etfs-tokenization-traders-reasons-for-the-most-bullish-crypto-setup">Trump, Bitcoin, Ethereum ETFs, Tokenization: Trader&#8217;s Reasons For The &#8216;Most Bullish Crypto Setup&#8217;</a>
CrypNuevo&#8217;s analysis provides valuable insights into Bitcoin&#8217;s potential movements. His assertion that the CME gap doesn&#8217;t need to be filled immediately could alleviate concerns about a potential immediate drop in Bitcoin&#8217;s price.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39838299/bitcoin-bounce-germanys-bitcoin-supply-hits-zero-markets-react">Bitcoin Bounce: Germany&#8217;s Bitcoin Supply Hits Zero, Markets React</a></li>
</ul>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Mid-Term Target: 3 Points You Need To Know

United Airlines Exec Says There Are A Ton Of Reasons To Expect Further Reductions In Industry Of Unprofitable Flying To Push Our FY Earnings Higher

Opko Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPK#NASDAQ">OPK</a>) shares are trading higher Thursday after the company announced a $100 million <a href="https://www.benzinga.com/pressreleases/24/07/g39835824/opko-health-announces-100-million-share-repurchase-program">share repurchase program.</a>
The Details:
Opko said it expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The company had approximately 697 million shares outstanding as of June 30, 2024, and the new authorization represents approximately 10.1% of shares outstanding at the current stock price.
Read Next:<a href="https://www.benzinga.com/news/earnings/24/07/39826835/discover-reports-better-than-expected-q2-results-heres-the-details"> Discover Reports Better-Than-Expected Q2 Results: Here&#8217;s The Details</a>
&#8220;We believe OPKO&#8217;s shares are significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO&#8217;s strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability,&#8221; said Phillip Frost, M.D., CEO of Opko Health.&nbsp;
Additionally, Opko announced a $250 million non-dilutive note <a href="https://www.benzinga.com/news/24/07/39827620/why-opko-health-shares-are-up-after-hours">purchase agreement </a>with HealthCare Royalty (HCRx) after the market close Wednesday. Opko said the purchase agreement is secured by its profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA, a once-weekly treatment to treat pediatric growth hormone deficiency.
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Opko Health shares are moving on heavy volume and are trading above the stock&#8217;s 50-day moving average of $1.31.&nbsp;
<h2 class="wp-block-heading">Should I Sell My OPK Stock?</h2>
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today. The stock has risen 24.15% over the past month, meaning an investor who bought shares on June 1 would see a capital gain of $0.12.
Opko Health shares have an all-time high of $5.15, representing 234.55% upside from current levels.
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Opko Health stock currently has an RSI of 84.21, indicating overbought conditions.
For access to advanced charting and analysis tools and stock data, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
OPK Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Opko Health shares are up 3.87% at $1.47 at the time of publication Thursday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39827454/what-happened-with-intel-stock-today">What Happened With Intel Stock Today?</a></li>
</ul>
Image: Shutterstock

Movers

Opko Health Stock Is Climbing: What's Going On?

AllianzIM U.S. Large Cap Buffer10 May ETF

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 May ETF

News

Latest news for AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 May ETF (ARCA:MAYT)